HUM - Humana Inc.
NYSE
->
Healthcare
->
Healthcare Plans
Louisville,
United States
Type: Equity
HUM price evolution
HUM
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $5501 | $5910 | $4694 | |
| Short term investments | $17424 | $16697 | $16626 | |
| Net receivables | $4090 | $3925 | $2035 | |
| Inventory | ||||
| Total current assets | $32858 | $32796 | $29986 | |
| Long term investments | $1124 | $1110 | $1122 | |
| Property, plant & equipment | $2693 | $2821 | $2979 | $3030 |
| Goodwill & intangible assets | $9567 | $9563 | $9550 | |
| Total noncurrent assets | $17235 | $17295 | $17079 | |
| Total investments | $18548 | $17807 | $17748 | |
| Total assets | $50007 | $50093 | $50091 | $47065 |
| Current liabilities | ||||
| Accounts payable | $5915 | $17973 | $18233 | $6569 |
| Deferred revenue | $313 | $301 | $266 | |
| Short long term debt | $1504 | $1155 | $1796 | |
| Total current liabilities | $7246 | $19790 | $19689 | $8278 |
| Long term debt | $11886 | $11746 | $12390 | $10213 |
| Total noncurrent liabilities | $13575 | $14216 | $11875 | |
| Total debt | $13250 | $13545 | $12009 | |
| Total liabilities | $32442 | $33365 | $33905 | $30803 |
| Shareholders' equity | ||||
| Retained earnings | $29118 | $28745 | $28173 | $27540 |
| Other shareholder equity | -$653 | -$1122 | -$1086 | -$999 |
| Total shareholder equity | $16671 | $16130 | $16262 | |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $4694 | $5061 | $3394 | $4673 |
| Short term investments | $16626 | $13881 | $13192 | $12554 |
| Net receivables | $2035 | $1674 | $1814 | $1138 |
| Inventory | ||||
| Total current assets | $29986 | $26183 | $24893 | $23641 |
| Long term investments | $1122 | $1129 | $921 | $2382 |
| Property, plant & equipment | $3030 | $3221 | $3073 | $2371 |
| Goodwill & intangible assets | $9550 | $9142 | $11092 | $4447 |
| Total noncurrent assets | $17079 | $16872 | $19465 | $11328 |
| Total investments | $17748 | $15010 | $14113 | $14936 |
| Total assets | $47065 | $43055 | $44358 | $34969 |
| Current liabilities | ||||
| Accounts payable | $6569 | $5238 | $12798 | $12156 |
| Deferred revenue | $266 | $286 | $254 | $318 |
| Short long term debt | $1796 | $2390 | $2279 | $920 |
| Total current liabilities | $8278 | $7914 | $15331 | $13394 |
| Long term debt | $10213 | $9034 | $10541 | $6060 |
| Total noncurrent liabilities | $11875 | $10507 | $12924 | $7847 |
| Total debt | $12009 | $11424 | $12820 | $6980 |
| Total liabilities | $30803 | $27744 | $28255 | $21241 |
| Shareholders' equity | ||||
| Retained earnings | $27540 | $25492 | $23086 | $20517 |
| Other shareholder equity | -$999 | -$1304 | $42 | $391 |
| Total shareholder equity | $16262 | $15311 | $16080 | $13728 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $29397 | $29540 | $29611 | |
| Cost of revenue | $25039 | $25124 | ||
| Gross Profit | $4501 | $4487 | ||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $3148 | $3042 | ||
| Total operating expenses | $28614 | $3360 | $3251 | |
| Operating income | $1141 | $1236 | ||
| Income from continuing operations | ||||
| EBIT | $1070 | $1151 | ||
| Income tax expense | $155 | $223 | $251 | |
| Interest expense | -$169 | $168 | $159 | |
| Net income | ||||
| Net income | $480 | $679 | $741 | |
| Income (for common shares) | $679 | $741 | ||
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Jan 2022 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $106374 | $92870 | $77155 | |
| Cost of revenue | $75690 | $61628 | ||
| Gross Profit | $17180 | $15527 | ||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $12671 | $10052 | ||
| Total operating expenses | $102361 | $13380 | $10541 | |
| Operating income | $3800 | $4986 | ||
| Income from continuing operations | ||||
| EBIT | $3969 | $4957 | ||
| Income tax expense | $836 | $762 | $1307 | |
| Interest expense | -$493 | $401 | $283 | |
| Net income | ||||
| Net income | $2489 | $2806 | $3367 | |
| Income (for common shares) | $2806 | $3367 | ||
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Net income | $679 | $741 | ||
| Operating activities | ||||
| Depreciation | $243 | $242 | ||
| Business acquisitions & disposals | -$3 | -$14 | ||
| Stock-based compensation | $55 | $45 | ||
| Total cash flows from operations | $1213 | $423 | ||
| Investing activities | ||||
| Capital expenditures | -$114 | -$177 | ||
| Investments | -$885 | -$223 | ||
| Total cash flows from investing | -$2889 | -$1002 | -$414 | -$3492 |
| Financing activities | ||||
| Dividends paid | -$323 | -$107 | -$109 | -$431 |
| Sale and purchase of stock | -$49 | -$717 | ||
| Net borrowings | -$265 | $1563 | ||
| Total cash flows from financing | -$183 | -$620 | $1207 | -$856 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $422 | -$409 | $1216 | -$367 |
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $2806 | $2933 | $3367 | |
| Operating activities | ||||
| Depreciation | $845 | $713 | $616 | |
| Business acquisitions & disposals | $2364 | -$4187 | -$709 | |
| Stock-based compensation | $216 | $180 | $181 | |
| Total cash flows from operations | $4587 | $2262 | $5639 | |
| Investing activities | ||||
| Capital expenditures | -$1120 | -$1316 | -$964 | |
| Investments | -$2250 | -$1053 | -$1392 | |
| Total cash flows from investing | -$3492 | -$1006 | -$6556 | -$3065 |
| Financing activities | ||||
| Dividends paid | -$431 | -$392 | -$354 | -$323 |
| Sale and purchase of stock | -$2096 | -$58 | -$1771 | |
| Net borrowings | -$1428 | $3733 | $1078 | |
| Total cash flows from financing | -$856 | -$1914 | $3015 | -$1955 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$367 | $1667 | -$1279 | $619 |
News
Fundamentals
| Market cap | $31.05B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 120.41M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | 11.26% |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.89 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |